Navigation Links
Mayo Clinic study shows drug could effectively treat, prevent the spread of breast cancer
Date:11/1/2007

ROCHESTER, Minn. -- A Mayo Clinic study of a drug that has shown promise in treating sarcoma, lung and brain cancers, demonstrates that the drug may also be effective in treating breast cancer, in particular the spread of breast cancer.

The study, which was done in mouse models, is featured on the cover of the November issue of Cancer Research.

The National Cancer Institute reports that of 240,510 breast cancer diagnoses each year, about 178,480 of those women will have invasive cancer that has spread. In breast cancer, the cancer commonly lodges in the bone, destroying it in a debilitating and painful process called osteolysis. Osteolysis can lead to bone fractures that release excess calcium into the blood causing patients to feel tired or even lose consciousness.

2-methoxyestradiol (meth-oxy-es-tra-di-ol), or 2ME2, (trade name Panzem), is currently in clinical trials by other researchers as a treatment for various cancers. Mayo Clinic recently completed a clinical trial of oral 2ME2 in multiple myeloma.

2ME2 is derived from estrogen and works by suppressing tumor growth and blocking the formation of new blood vessels that feed tumors.

2ME2 could benefit patients because this single drug essentially combines the effects of chemotherapy (which destroys cancer cells) and antiangiogenesis drugs (which destroy blood vessels that feed tumors), states Muzaffer Cicek, Ph.D., a Mayo Clinic cell biologist in endocrine research and the corresponding author of the study.

A key part of the study is in 2ME2's ability to induce cancer cells to self-destruct, a process called apoptosis. Cells have the ability to self-destruct when damaged or infected with a virus, for example. But if a damaged cell is unable to self-destruct, it can develop into a tumor. Other studies of 2ME2 tested in other cancers, show that 2ME2 could induce cancer cells to self-destruct.

Dr. Cicek and colleagues conducted experiments in m
'/>"/>

Contact: Amy Reyes
newsbureau@mayo.edu
507-284-5005
Mayo Clinic
Source:Eurekalert

Page: 1 2 3

Related medicine news :

1. Scientists plan human cloning clinic in the United States
2. How do patients benefit of clinical trials
3. Magnetic resonance angiography in clinical medicine
4. Clinical trials need to be more frank
5. AEternas acquisition of Zentaris being followed up with its new product pipeline and clinical development strategy
6. Physicians Lack Clinical Guidelines For Treating Elderly With Multiple Illnesses
7. The Growing Rise In Clinical Research Could Lead To A Compromise In Quality Of Research And Ethics
8. Clinical Comparisons Between ADHD Drugs Are Less
9. Specialized Clinics For Manipurs AIDS Patients
10. Outsourcing clinical trials to India
11. Erectile dysfunction: an early warning sign of clinically silent coronary artery disease?
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2008)...es Latinos to Get Tested, LOS ANGELES, Oct. 13 /P...alf of all newly diagnosed HIV/AIDS cases,reported...onally., -- A week of activities aimed at raising...ing to coincide with National Latino AIDS Awarenes... Community, Our Responsibility: Latinos in Action ...
(Date:10/13/2008)...ew or existing customers., BOTHELL, Wash., Oct. 1...ation (Nasdaq: CSCX ) announced today that it has...action of certain automated external,defibrillator...h 2007. Some,AEDs manufactured in this time frame ...ch the factory software settings. Under a particul...
(Date:10/13/2008)... ever before, study finds , , MONDAY, ...er are being treated for high blood pressure, say ...d Blood Institute. , The major factor in the dr...gh blood pressure appears to be the obesity epidem...ditional efforts are needed to prevent hypertensio...
(Date:10/13/2008)... in national study Study needed because of l...Oct. 13 /PRNewswire/ -- Advanced Circulatory Syste...nounced today that it has,received an additional $...s,of Health (NIH) to continue a study testing two ...e cardiac arrest outside a hospital. Oshkosh is on...
Breaking Medicine News(10 mins):Health News:Nearly Half of Newly Diagnosed HIV/AIDS Cases in Los Angeles County Are Among Latinos 2Health News:Cardiac Science Initiates Voluntary Field Corrective Action of Certain AEDs 2Health News:Cardiac Science Initiates Voluntary Field Corrective Action of Certain AEDs 3Health News:Blood Pressure on the Rise in America 2Health News:Blood Pressure on the Rise in America 3Health News:Advanced Circulatory Systems Receives $1.5 Million From NIH for Study of Cardiac Arrest Resuscitation Techniques 2
...ination of pet food continues to takes it toll in ... Calinfornia //was placed under quarantine followi...n pig urine in the farm. Additional testing was u...s present in the meat produced by that farm since ...
...knee pain that refused to go for a decade, but was...c therapy, has prompted an NRI to bring the Scandi...ashyap, a 62-year-old Sweden-based businessman, ha...ro Magnetic Field (PEMF) therapy, which sends magn...
... a polluted river and a handful of concerned citiz..., heralded World Earth Day Sunday, //by raising it...agile ecosystem. 'We are on the brink of a challe...k, an environmental NGO. 'The issue of stopping de...
...me to get children especially the eight to 12-year...ded success. The MEND programme, as it is called, ...This programme is opportune, considering that 30% ...eight or obese. MEND - for Mind, Exercise, Nutriti...
Other Medicine News:Health News:Pigs Quarantined in US Farm Following Melamine Contamination 2Health News:NRI Brings to India Effective Pain Relief Therapy 2Health News:Earth Day Celebrated With Hopes of a Greener Tomorrow 2Health News:MEND - Child Obesity Programme Records Success 2
(Date:10/12/2008)...and WASHINGTON, Oct. 12 /- ...announced results from an analysis,of nearly 7,500..., which,are designed to confirm the performance of...nary Stent System in real-world practice. The,two-...t reduced clinical,restenosis in patients with dia...
(Date:10/10/2008)...Mich., Oct. 10 /- Diplomat Specialty,...s selected Diplomat,Specialty Pharmacy to be one o..., national Therapy Optimization Study for Multiple...OP MS study, is to examine the benefits of a,speci...ance, adherence and,patient outcomes. Targeted pat...
(Date:10/10/2008)..., Oct. 10 /- Inverness Medi...vider of near-patient,diagnostics, monitoring and ...n Ki-moon, the Secretary-General of the United Nat...eventeen of the world,s leading,research-based and...Inverness, together with senior officials from the...
(Date:10/10/2008)...lif., Oct. 10 /- TriReme Medical Inc.... to affix the CE (Conformite,Europeenne) marking a...y,Stent System, a unique main vessel stent system ...urcations., Representing the next generation in b...tential use in a quarter of the 2.2 million,angiop...
Breaking Medicine Technology:TAXUS(R) Express(R) Stent Shows Similarly Low Re-Intervention Rates in Patients With Diabetes Compared to Non-Diabetics in Arrive Registry Program 2TAXUS(R) Express(R) Stent Shows Similarly Low Re-Intervention Rates in Patients With Diabetes Compared to Non-Diabetics in Arrive Registry Program 3TAXUS(R) Express(R) Stent Shows Similarly Low Re-Intervention Rates in Patients With Diabetes Compared to Non-Diabetics in Arrive Registry Program 4TAXUS(R) Express(R) Stent Shows Similarly Low Re-Intervention Rates in Patients With Diabetes Compared to Non-Diabetics in Arrive Registry Program 5Diplomat Specialty Pharmacy Tapped by Teva Neuroscience for Therapy Optimization Study for Multiple Sclerosis (TOP MS) 2Inverness Medical Innovations Participates in Meeting on HIV/AIDS with UN Secretary-General 2Inverness Medical Innovations Participates in Meeting on HIV/AIDS with UN Secretary-General 3TriReme Medical Inc. Receives CE Marking for Antares(TM) Coronary Stent System 2Leading Childrens Hospital Utilizes MEDais Solutions to Deliver Outstanding Care 4025 1Leading Childrens Hospital Utilizes MEDais Solutions to Deliver Outstanding Care 4025 2Nventa updates progress of cervical dysplasia trial with new HspE7 1339 1Nventa updates progress of cervical dysplasia trial with new HspE7 1339 2Nventa updates progress of cervical dysplasia trial with new HspE7 1339 3Nventa updates progress of cervical dysplasia trial with new HspE7 1339 4Nventa updates progress of cervical dysplasia trial with new HspE7 1339 5Nile Therapeutics Appoints Pedro Granadillo to Board of Directors 1334 1Nile Therapeutics Appoints Pedro Granadillo to Board of Directors 1334 2Nile Therapeutics Appoints Pedro Granadillo to Board of Directors 1334 3FDA Panel Mulls Ban on Kids Cold Medicines 4019 1FDA Panel Mulls Ban on Kids Cold Medicines 4019 2FDA Panel Mulls Ban on Kids Cold Medicines 4019 3FDA Panel Mulls Ban on Kids Cold Medicines 4019 4
...is a national reference laboratory and a worldwide...lopment. ARUP offers an extensive test menu of hig...nd anatomic pathology. Owned by the University of ... half of the nation's university teaching hospital...
...is a national reference laboratory and a worldwide...lopment. ARUP offers an extensive test menu of hig...nd anatomic pathology. Owned by the University of ... half of the nation's university teaching hospital...
...is a national reference laboratory and a worldwide...lopment. ARUP offers an extensive test menu of hig...nd anatomic pathology. Owned by the University of ... half of the nation's university teaching hospital...
...is a national reference laboratory and a worldwide...lopment. ARUP offers an extensive test menu of hig...nd anatomic pathology. Owned by the University of ... half of the nation's university teaching hospital...
Medicine Products: